PO-370 A co-culture assay system using engineered anti-CD3 tumour cells to assess tumour cell sensitivity to CD8 +T cell killing

ESMO Open - Tập 3 - Trang A373-A374 - 2018
N. Nelson1, M. Lopez-Pelaez1, A. Palazon2, R. Wilkinson2, S. Dovedi2, P. Smith1
1AstraZeneca, Bioscience- Oncology- IMED Biotech Unit, Cambridge, UK
2MedImmune, Oncology, Cambridge, UK